Zobrazeno 1 - 6
of 6
pro vyhledávání: '"H M, Bandara"'
Autor:
Washim Khan, Yan-Hong Wang, Narayan D. Chaurasiya, N. P. Dhammika Nanayakkara, H. M. Bandara Herath, Kerri A. Harrison, Gray Dale, Donald A. Stanford, Eric P. Dahl, James D. McChesney, Waseem Gul, Mahmoud A. ElSohly, David Jollow, Babu L. Tekwani, Larry A. Walker
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2023)
Primaquine (PQ) is an 8-aminoquinoline antimalarial, active against dormant Plasmodium vivax hypnozoites and P. falciparum mature gametocytes. PQ is currently used for P. vivax radical cure and prevention of malaria transmission. PQ is a racemic drug
Externí odkaz:
https://doaj.org/article/801eb27d382a49469704097ef32cf698
Autor:
Pius S. Fasinu, N. P. Dhammika Nanayakkara, Yan-Hong Wang, Narayan D. Chaurasiya, H. M. Bandara Herath, James D. McChesney, Bharathi Avula, Ikhlas Khan, Babu L. Tekwani, Larry A. Walker
Publikováno v:
Malaria Journal, Vol 18, Iss 1, Pp 1-8 (2019)
Abstract Background The activity and haemolytic toxicity associated with primaquine has been linked to its reactive metabolites. The reactive metabolites are thought to be primarily formed through the action of cytochrome P450-mediated pathways. Huma
Externí odkaz:
https://doaj.org/article/bef9c2cb44b441a495645be8bf521194
Autor:
Khan, Washim, Yan-Hong Wang, Chaurasiya, Narayan D., Nanayakkara, N. P. Dhammika, Herath, H. M. Bandara, Harrison, Kerri A., Dale, Gray, Stanford, Donald A., Dahl, Eric P., McChesney, James D., Gul, Waseem, ElSohly, Mahmoud A., Jollow, David, Tekwani, Babu L., Walker, Larry A.
Publikováno v:
Frontiers in Pharmacology; 1/16/2023, Vol. 13, p1-13, 13p, 2 Charts, 7 Graphs
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Maheshi Yapa, Amali Manchanayaka, H M Bandara, Udayanthi Nanayakkara, Vajira Senaratne, L M Bandara, Mangala Gunatilake, P L D Senevirathne
Publikováno v:
The FASEB Journal. 28
Publikováno v:
The Ceylon medical journal. 30(3)